Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | trans-4-hydroxyproline | 2785 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 5198 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 5833 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 6046 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 6713 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 6772 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 6820 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 7588 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 7786 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 8099 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 8254 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 8651 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 8667 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 10132 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 10462 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 10514 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 10876 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 10880 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 11790 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 12791 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 12841 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 12873 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 13271 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 13315 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 13541 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 13803 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 13883 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 14340 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 14381 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 14626 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 14894 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 15204 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 15330 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 15380 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 15460 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 16223 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 16226 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 16904 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 17407 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 18560 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 18744 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 20223 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 20266 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 20301 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 20915 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 22988 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 23744 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 24344 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 27450 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 27451 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 28688 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 30843 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 32373 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 50647 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 58077 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 58262 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 60577 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 104608 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |